Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析

◆英語タイトル:Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15754
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Integra LifeSciences Holdings Corp (IART) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra’s products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

Mar 14,2019 Integra LifeSciences Announces the Approval of DuraGen® in Japan | Integra LifeSciences Holdings Corporation
Feb 21,2019 Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09,2019 Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09,2019 Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Integra LifeSciences Holdings Corp – Key Facts
Integra LifeSciences Holdings Corp – Key Employees
Integra LifeSciences Holdings Corp – Key Employee Biographies
Integra LifeSciences Holdings Corp – Major Products and Services
Integra LifeSciences Holdings Corp – History
Integra LifeSciences Holdings Corp – Company Statement
Integra LifeSciences Holdings Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Integra LifeSciences Holdings Corp – Business Description
Business Segment: Codman Specialty Surgical
Overview
Performance
Business Segment: Orthopedics and Tissue Technologies
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Integra LifeSciences Holdings Corp – Corporate Strategy
Integra LifeSciences Holdings Corp – SWOT Analysis
SWOT Analysis – Overview
Integra LifeSciences Holdings Corp – Strengths
Integra LifeSciences Holdings Corp – Weaknesses
Integra LifeSciences Holdings Corp – Opportunities
Integra LifeSciences Holdings Corp – Threats
Integra LifeSciences Holdings Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 14, 2019: Integra LifeSciences Announces the Approval of DuraGen® in Japan | Integra LifeSciences Holdings Corporation
Feb 21, 2019: Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance
Jan 09, 2019: Integra LifeSciences appoints Rhonda Germany Ballintyn as Director
Jan 09, 2019: Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation
Jan 08, 2019: Integra LifeSciences announces preliminary fourth quarter 2018 financial results
Nov 20, 2018: Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
Oct 31, 2018: Integra LifeSciences reports third quarter 2018 financial results
Sep 05, 2018: 2018 Veeva R&D summit to showcase advances for speeding product development
Jul 25, 2018: Integra LifeSciences Reports Second Quarter 2018 Financial Results
May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Integra LifeSciences Holdings Corp, Performance Chart (2014 - 2018)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務分析
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • co.don AG (CNWK):企業概要、財務及び戦略的SWOT分析
    Summary co.don AG (co.don) is a bio-pharmaceutical company. The company develops, produces and markets autologous, cell-based pharmaceutical products for biological repair, regeneration and functional maintenance of musculoskeletal system. It undertakes tissue engineering for the cultivation and gro …
  • Palfinger AG (PAL):企業の財務・戦略的SWOT分析
    Palfinger AG (PAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Agios Pharmaceuticals Inc (AGIO):医療機器:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Halliburton Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Halliburton Company Mergers and …
  • Pulmatrix, Inc.(製薬・医療分野):企業M&A動向
    Summary Pulmatrix, Inc. (Pulmatrix) is a biotechnology company. The company discovers and develops inhaled therapies for the prevention and treatment of respiratory diseases. Its iSPERSE powders are used with an array of dry powder inhaler technologies and can be formulated any drug substance. The c …
  • Radius Health, Inc. (RDUS)(製薬・医療分野):企業M&A動向
    Summary Radius Health, Inc. (Radius Health) is a pharmaceuticals and healthcare company. The company discovers and develops new generation of drug for osteoporosis and women’s health. Radius Health develops anabolic drugs for metabolic bone diseases and drugs for reproductive disorders. The company …
  • PT Leyand International Tbkの企業概要及び財務/SWOT分析
    PT Leyand International Tbk Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and qua …
  • Aconex Ltd.:企業の戦略・SWOT・財務分析
    SummaryAconex Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Mayne Pharma Group Ltd (MYX)-製薬・医療分野:企業M&A・提携分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd, a subsidiary of Hospira Inc, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise astrix capsules and tablets, erymax cap …
  • Stem Cell Theranostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stem Cell Theranostics Inc (Stem Cell Theranostics) is a biotechnology company that develops genetically-targeted therapies for heart failure. The company discovers and develops novel medicines for heart diseases using stem cell-derived, patient-specific cardiac disease models. It also devel …
  • Aileron Therapeutics Inc:企業のM&A・提携動向(医療分野)
    Summary Aileron Therapeutics Inc (Aileron) is a clinical-stage biopharmaceutical company that develops and commercializes novel class of therapeutics. The company offers products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protei …
  • RadiSys Corporation (RSYS):企業財務及び戦略的SWOT分析
    Summary RadiSys Corporation (RadiSys) is a technology company that develops software and integrated systems for telecommunications industry, including SDN/NFV and cloud architectures, LTE networks, and IMS service delivery. The company’s product portfolio comprise security gateway, COM express, netw …
  • United-Guardian, Inc. (UG):企業の財務及び戦略的SWOT分析
    Summary United-Guardian, Inc. (United-Guardian) is a diversified business company that does research, product development, manufactures and markets pharmaceuticals, cosmetic ingredients, health care products, medical devices and other industrial products. Its products include in personal care and co …
  • Cavitation Technologies, Inc. (CVAT):企業の財務及び戦略的SWOT分析
    Summary Cavitation Technologies, Inc. (Cavitation) is an energy service company that develops and offers processing technologies. The company caters its technologies to edible oil refining, algal oil extraction and renewable fuel production, alcoholic beverage enhancement, water treatment and expedi …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業財務及び戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals) is a pharmaceutical company that develops next-generation synthetic cannabinoid therapeutics. The company’s products comprise pro-drug of THC transdermal patch and permeation-enhanced gel. The company provides transdermal delivery for pat …
  • Transurban Groupの企業概要及び財務/SWOT分析
    Transurban Group Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Transurban Group annual and quarterly forecasts made by stock market experts. The report also enables direct …
  • PeptiDream Inc (4587)-製薬・医療分野:企業M&A・提携分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform. Its technologies i …
  • Skanray Technologies Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company. It provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surgi …
  • TKH Group NV (TWEKA):企業概要、財務及び戦略的SWOT分析
    Summary TKH Group NV (TKH) is a technology service provider. The company provides technology services. Its solutions include telecom solutions, building solutions, and industrial solutions. TKH's telecom solutions include fibre network systems, copper network systems, and indoor telecom systems. The …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆